Valuation: RaySearch Laboratories AB

Market Cap 597.89Cr 62Cr 54Cr 50Cr 46Cr 87Cr 5.97TCr 89Cr 234.87Cr 2.92TCr 232.79Cr 227.66Cr 10TCr P/E 2026 *
21.1x
P/E 2027 * 17.2x
Enterprise Value 613.59Cr 64Cr 56Cr 51Cr 47Cr 89Cr 6.13TCr 91Cr 241.04Cr 3TCr 238.91Cr 233.64Cr 10TCr EV / Sales 2026 *
4.35x
EV / Sales 2027 * 3.62x
Free-Float
80.09%
Yield 2026 *
2.29%
Yield 2027 * 2.91%
1 day-4.30%
1 week-25.77%
Current month-20.90%
1 month-16.57%
3 months-24.15%
6 months-18.55%
Current year-23.98%
1 week 161
Extreme 161
234.4
1 month 161
Extreme 161
236.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
368
3 years 63.1
Extreme 63.1
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-4.30%-25.77% - - 62Cr
-1.01%+2.77%-29.33%-5.55% 3.17TCr
-3.46%-5.05%-43.38%+183.84% 1.36TCr
-1.43%-2.55%-24.35%+66.69% 550.1Cr
-4.20%-6.89% - - 214.57Cr
-2.40%+2.11%+64.00%-35.71% 208.61Cr
-0.73%-5.34% - - 173.83Cr
-4.23%-2.47%-38.47% - 106.54Cr
-3.80%-5.00%+45.22%+102.67% 90Cr
-6.74%-2.64%-41.45%-56.77% 76Cr
Average -3.23%-2.78%-9.68%+42.53% 662.04Cr
Weighted average by Cap. -1.96%-0.40%-27.92%+48.96%

Financials

2026 *2027 *
Net sales 141.2Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.41TCr 21Cr 55Cr 690.29Cr 55Cr 54Cr 2.4TCr 164.75Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.64TCr 24Cr 65Cr 805.42Cr 64Cr 63Cr 2.8TCr
Net income 28Cr 2.9Cr 2.54Cr 2.34Cr 2.16Cr 4.07Cr 279.5Cr 4.16Cr 11Cr 136.88Cr 11Cr 11Cr 475.22Cr 34Cr 3.54Cr 3.09Cr 2.85Cr 2.63Cr 4.96Cr 340.4Cr 5.07Cr 13Cr 166.71Cr 13Cr 13Cr 578.75Cr
Net Debt 16Cr 1.63Cr 1.42Cr 1.31Cr 1.21Cr 2.28Cr 156.72Cr 2.33Cr 6.17Cr 77Cr 6.11Cr 5.98Cr 266.46Cr -70L -7L -6L -6L -5L -10.18L -6.99Cr -10.4L -27.5L -3.42Cr -27.26L -26.65L -12Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
17/26/17 SEK 179.45 +6.11% 10,809
16/26/16 SEK 169.11 -23.91% 45,937
15/26/15 SEK 222.25 -2.52% 1,512
14/26/14 SEK 228.00 -1.54% 16,673
13/26/13 SEK 231.56 -1.04% 1,961
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
174.40SEK
Average target price
330.00SEK
Spread / Average Target
+89.22%

Quarterly revenue - Rate of surprise